GLP-1 analogues GLP-1 analogues were first approved for the treatment of T2DM in 2005
If fatigue is a major issue, address hydration, nutrition, sleep, and semaglutide management strategies first
[304] The impact of habitual indulgence in coffee, tea, and alcohol on eye Health Habitual indulgence in certain substances (coffee, tea, alcohol, and cigarette smoking) can have both positive and negative effects on eye health
Sermorelin may be more appropriate when the focus is systemic recovery, growth hormone support, sleep, energy, and body composition
Obesity drug coverage in Medicaid remains limited, with 13 state Medicaid programs covering GLP-1s for obesity treatment under FFS as of January 2026 (Figure 1)
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids derived from a partial sequence of human gastric juice protein